These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7660157)

  • 1. The Thrombostat 4000. A sensitive screening test for von Willebrand's disease.
    Weippert-Kretschmer M; Witte M; Budde U; Vigh T; Kretschmer V; Scharrer I
    Semin Thromb Hemost; 1995; 21 Suppl 2():44-51. PubMed ID: 7660157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
    Schlammadinger A; Kerenyi A; Muszbek L; Boda Z
    Thromb Haemost; 2000 Jul; 84(1):88-92. PubMed ID: 10928476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Willebrand factor ristocetin cofactor (VWF:RCo) assay: implementation on an automated coagulometer (ACL).
    Redaelli R; Corno AR; Borroni L; Mostarda G; Nichelatti M; Morra E; Baudo F
    J Thromb Haemost; 2005 Dec; 3(12):2684-8. PubMed ID: 16359507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
    Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
    Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels.
    Bucciarelli P; Siboni SM; Stufano F; Biguzzi E; Canciani MT; Baronciani L; Pagliari MT; La Marca S; Mistretta C; Rosendaal FR; Peyvandi F
    J Thromb Haemost; 2015 Feb; 13(2):228-36. PubMed ID: 25425019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for von Willebrand disease: contribution of an automated assay for von Willebrand factor activity.
    Lasne D; Dey C; Dautzenberg MD; Cherqaoui Z; Monge F; Aouba A; Torchet MF; Geloen D; Landais P; Rothschild C
    Haemophilia; 2012 May; 18(3):e158-63. PubMed ID: 21951857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S; Mezzasoma AM; Leone M; Gresele P
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.
    Favaloro EJ; Facey D; Henniker A
    Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
    Castaman G; Federici AB; Rodeghiero F; Mannucci PM
    Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
    Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ABO blood groups on primary hemostasis.
    Moeller A; Weippert-Kretschmer M; Prinz H; Kretschmer V
    Transfusion; 2001 Jan; 41(1):56-60. PubMed ID: 11161246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen.
    Stufano F; Lawrie AS; La Marca S; Berbenni C; Baronciani L; Peyvandi F
    Haemophilia; 2014 Jan; 20(1):147-53. PubMed ID: 24028703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High-shear force-induced platelet aggregation in the screening and diagnosis of von Willebrand disease].
    Schlammadinger A; Kerényi A; Muszbek L; Boda Z
    Orv Hetil; 2000 Oct; 141(41):2245-50. PubMed ID: 11184249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand's disease: case report and review of literature.
    Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
    Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of current diagnostic practice and efficacy in testing for von Willebrand's disorder: results from the second Australasian multi-laboratory survey.
    Favaloro EJ; Thom J; Baker R;
    Blood Coagul Fibrinolysis; 2000 Dec; 11(8):729-37. PubMed ID: 11132651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new flow cytometric method for measurement of von Willebrand factor activity.
    Lindahl TL; Fagerberg IH; Larsson A
    Scand J Clin Lab Invest; 2003; 63(3):217-23. PubMed ID: 12817908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an automated von Willebrand factor activity assay in von Willebrand disease.
    Trossaërt M; Ternisien C; Lefrancois A; Llopis L; Goudemand J; Sigaud M; Fouassier M; Caron C
    Clin Appl Thromb Hemost; 2011; 17(6):E25-9. PubMed ID: 20724302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.